Osler, Hoskin & Harcourt LLP advised Inversago Pharma on the matter. On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Nichi-Iko Pharmaceutical Co. on the sale. Nichi-Iko Pharmaceutical Co., Ltd. sold all issued and outstanding shares of its wholly owned...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised CDPQ on the equity investment in Pomerleau Inc. On December 7, 2022, Caisse de dépôt et Placement du Québec (“CDPQ”)...
You must be a Standard 1 Year member to access this content.
Fasken supported NuChem Sciences Inc. on the acquisition of IniXium Inc., assisted by Osler, Hoskin & Harcourt LLP. Blakes represented the Fonds de solidarité FTQ. NuChem...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Québecor on the acquisition. Goodmans LLP acted for Rogers Communications Inc. On August 12, 2022, Québecor (TSE:QBR.B) , a Canadian leader...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Bailey International on the deal. EBSCO Capital has acquired Hydrolico International Inc. for EBSCO Industries’ portfolio company, Bailey International, LLC (Bailey),...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP acted for BBH Capital Partners on the matter. BBH Capital Partners entered into an investment agreement with Synex Business Performance Group for...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP served as legal counsel and UBS Investment Bank as financial advisor to Zebra.?Stikeman Elliott LLP acted as legal counsel and Evercore...
You must be a Standard 1 Year member to access this content.
